Date	Period	Revenue/Estimate	Earnings Call
--	2024/Q4	-- / 880.893M	--
Oct 26, 2024	2024/Q3	600.043M / 609.246M	--
Aug 24, 2024	2024/Q2	690.900M / 753.415M	--
--	2023/Q4	689.154M / 742.660M	--
Oct 31, 2023	2023/Q3	477.034M / 374.394M	--

DatePeriodRevenue/EstimateEarnings Call

--2024/Q4-- / 880.893M--

Oct 26, 20242024/Q3600.043M / 609.246M--

Aug 24, 20242024/Q2690.900M / 753.415M--

--2023/Q4689.154M / 742.660M--

Oct 31, 20232023/Q3477.034M / 374.394M--

Unlock Free Earnings Estimates

Open Account

Announcement of Guangdong Marumi Biotechnology Co., Ltd. on the main operating data for the third quarter of 2024

Oct 25, 2024 12:00 ET

Guangdong Marumi Biotechnology Co., Ltd. Report for the Third Quarter of 2024

Oct 25, 2024 12:00 ET

Guangdong Wanmei Biotechnology Co., Ltd.'s semi-annual report for 2024.

Aug 23, 2024 12:00 ET

Summary of Guangdong Wanmei Biotechnology Co., Ltd.'s 2024 interim report

Aug 23, 2024 12:00 ET

Symbol Price % Chg

See the daily top gainer.

Analysis

Updated: Mar 22, 2025

Strong Buy

No Data